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Mutations in the Embryonal Subunit of the Acetylcholine
Receptor (CHRNG) Cause Lethal and Escobar Variants of Multiple
Pterygium Syndrome
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Multiple pterygium syndromes (MPSs) comprise a group of multiple-congenital-anomaly disorders characterized by web-
bing (pterygia) of the neck, elbows, and/or knees and joint contractures (arthrogryposis). In addition, a variety of de-
velopmental defects (e.g., vertebral anomalies) may occur. MPSs are phenotypically and genetically heterogeneous but
are traditionally divided into prenatally lethal and nonlethal (Escobar) types. To elucidate the pathogenesis of MPS, we
undertook a genomewide linkage scan of a large consanguineous family andmapped a locus to 2q36-37.We then identiﬁed
germline-inactivating mutations in the embryonal acetylcholine receptor g subunit (CHRNG) in families with both lethal
and nonlethal MPSs. These ﬁndings extend the role of acetylcholine receptor dysfunction in human disease and provide
new insights into the pathogenesis and management of fetal akinesia syndromes.
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Multiple pterygia are found infrequently in children with
arthrogryposis and in fetuses with fetal akinesia syndrome.1
Inheritance can be autosomal dominant, autosomal re-
cessive, or X linked, but autosomal recessive inheritance
appears to be most common. Clinical expression is very
variable, and, in the severest form, lethal multiple pter-
ygium syndrome (LMPS [MIM 253290]), there is intra-
uterine growth retardation, multiple pterygia (e.g., chin
to sternum, cervical, axillary, humero-ulnar, crural, pop-
liteal, and ankles), and ﬂexion contractures causing severe
arthrogryposis and fetal akinesia. Subcutaneous edema
can be severe, causing fetal hydrops with cystic hygroma
and lung hypoplasia. Oligohydramnios and facial anom-
alies—in particular, cleft palate—are frequent. In addition,
internal anomalies—including cryptorchidism, intestinal
malrotation, cardiac hypoplasia, diaphragmatic hernia, ob-
structive uropathy, microcephaly, or cerebellar and pontine
hypoplasia—are described.2,3 Although, in some cases, an
underlying causative pathology of the brain, spinal cord,
or skeletal muscle may be identiﬁed, in many cases, the
etiology is not apparent.4 Inheritance is usually autosomal
recessive. The second major type of multiple pterygium
syndrome (MPS) is the milder, nonlethal Escobar variant
(EVMPS [MIM 265000]). This is also characterized bymul-
tiple pterygia, arthrogryposis, facial dysmorphism, short
stature, vertebral fusion, and other internal anomalies and
is usually transmitted as an autosomal recessive trait.5,6
To our knowledge, the molecular basis for LMPS and
EVMPS has not been characterized elsewhere, although
linkage to two arthrogryposis loci was excluded in a large
kindred with variant MPS.6 To identify a gene for MPS, we
undertook genetic-mapping studies in a large Arabkindred
(MPS001) with ﬁve affected individuals (see ﬁg. 1). The
proband, V-7, had pterygia of the elbows, axillae, poplitea,
thumb, and neck and facial dysmorphism (ptosis, down-
slanting palpebral ﬁssures, and expressionless face) and
rocker-bottom feet (ﬁg. 2). In addition, he has some fused
thoracic vertebrae, a large eventration of the right dia-
phragm, and normal intelligence. Two affected siblings
died in the neonatal period (a sister died at age 3 mo
because of congenital heart disease, and a brother died at
age 3 d because of lung hypoplasia). The four living af-
fected cousins (V-3, V-4, V-10, and V-12) were reported
to have pterygia similar to that of the proband. We per-
formed a genomewide linkage scan of affected individuals
from the MPS001 kindred, by use of 5,572 SNPs from the
Illumina SNP-based linkage IV panel. A single region of
extended homozygosity shared by all affected individuals
was then further analyzed by typing microsatellite mark-
ers in all 14 family members (5 affected) and in 4members
of a second family with EVMPS (MPS002) that contained
two affected sisters born to a healthy ﬁrst-cousin couple
of Pakistani origin (ﬁg. 1). After uneventful pregnancies and
deliveries, both sisters were noted at birth to have neck
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Figure 1. Pedigrees for families included in this study
pterygia, rocker-bottom feet, and clenched hands and to
be mildly dysmorphic, with epicanthic folds. During child-
hood, they developed signiﬁcant kyphoscoliosis that re-
quired surgery. Detailed review of one sister at age 22 years
revealed facial dysmorphism (down-slanting palpebral ﬁs-
sures), high-arched palate, short stature (height 145.5 cm
[!1st percentile], weight 48 kg [9th percentile]), kyphosco-
liosis, relative macrocephaly (occipital-frontal circumfer-
ence 75th–90th percentile), a short webbed neck, ﬁxed
ﬂexion contractures at the proximal interphalangeal joints
of all ﬁngers, adducted thumbs with lack of skin creases
at the distal interphalangeal joints of ﬁngers 2–4, mild
limitation of wrist extension, shoulder abduction and hip
extension, webbing between the ﬁrst and second ﬁngers,
and hypoplastic thenar eminences. Muscle bulk was good,
with no demonstrable muscle weakness and no history of
fatigue.
Genetic linkage studies conﬁrmed a region of homo-
zygosity at 2q36-q37 in affected individuals from both
families. A common 6.68-Mb region of overlap between
D2S1363 and D2S206 was identiﬁed, with a maximum
two-point LOD score of 4.28 at recombination fraction (v)
0 (under the assumption of equal allele frequencies) at
D2S2193 for family MPS001 (ﬁg. 3). We constructed an in
silico genomic map of the region, using public databases
(Ensembl Genome Browser), and prioritized genes for mu-
tation screening on the basis of putative function and
expression patterns. After failing to ﬁnd mutations in a
hypothetical gene, similar to tropomyosin 3 (TPM3), we
analyzed CHRNG and identiﬁed a homozygous nonsense
mutation in MPS002 (c.136CrT; p.Arg46X) and a mis-
sense substitution in MPS001 (c.320TrG; p.Val107Gly).
Each of these acetylcholine receptor subunits comprises a
large extracellular N-terminal ligand-binding region, three
hydrophobic transmembrane domains, a large intracel-
lular region, and a fourth hydrophobic domain (ﬁg. 4).
The c.136CrT mutation was predicted (in the absence of
nonsense-mediated decay) to encode a 46-aa protein lack-
ing the four transmembrane domains and intracellular
loop domain (ﬁg. 4). The c.136CrT mutation was not
detected in 384 Asian control chromosomes, and the
c.320TrG substitution was not present in 384 Asian and
white (192 of each) and 84 Arabic control chromosomes.
The p.Val107 residue is conserved in chimpanzee, cow,
rat, mouse, chick, and frog CHRNG proteins.
We then analyzed 13 further kindreds (7 with LMPS
and 6 with EVMPS) for CHRNG mutations (see ﬁg. 1 and
table 1). In MPS015, a homozygous frameshift mutation
(c.401_402delCT; p.Pro134Argfsx34) was identiﬁed in a
14-year-old boy with an EVMPS phenotype. He was born
at 35 wk of gestation by emergency cesarean section be-
cause of fetal distress and decreased fetal movement, and
he was ventilated from birth for 2 d because of poor re-
spiratory effort. At birth, he was noted to have ﬁxed ﬂex-
ion deformities with restricted movements at shoulder,
elbow, wrist, ﬁnger, hip, and knee joints. Pterygia were
present across large joints, from the neck to upper ster-
num, and at elbow, hip, and knee joints (see ﬁg. 2). In-
tellectual development is normal. At age 18 mo, some
paucity of facial expression and reduced muscle bulk with
general mild weakness and absence of tendon reﬂexes
were noted. Amuscle biopsy at age 22mo showed normal-
sized ﬁbers with normal peripheral distribution of nuclei.
An increase in collagen, separating the muscle ﬁbers into
smaller-than-usual fascicles, was also noted. Muscle ultra-
sound showed extensive echogenicity in all muscles ex-
amined, in keeping with diffuse myopathy, and electro-
myography showed no evidence of active or progressive
disorder but was clearly myopathic, with frequent low-
amplitude, short-duration polyphasic potentials.
Germline CHRNG-truncating mutations were found in
two kindreds with LMPS (see table 1). A homozygous frame-
shift mutation (c.753_754delCT; p.Pro251ProfsX46) was
identiﬁed in MPS008; a male fetus was found, on ultra-
sound scan at 13 wk of gestation, to have hydrops. The
hydrops worsened, and the pregnancy was terminated at
15 wk of gestation. At autopsy, there was extensive loose
skin over the body, consistent with severe hydrops prior
to delivery, and facial dysmorphism, including down-
slanting palpebral ﬁssures, very-low-set ears, and marked
micrognathia. There was marked deviation of the wrists
and severe bilateral talipes. Internal examination revealed
an unﬁxed colon, absent left umbilical, and a mild tho-
racic scoliosis. Muscle bulk was generally reduced, and
muscle histology demonstrated an abnormal myotubu-
lar appearance (see ﬁg. 2). A homozygous frameshift mu-
tation (c.469dupA; p.Val154SerfsX24) (see table 1) was
identiﬁed in a 37-wk female fetus (MPS011) found to be
hydropic, with bilateral moderate pleural effusions, skin
edema, and hydronephrotic right kidney. An emergency
cesarean section was performed for fetal distress, but the
baby died at age 1 d because of lung hypoplasia. At au-
topsy, contractures of all extremities, early webs in the
groin and elbow, and rocker-bottom feet were noted. In-
ternal examination revealed bilateral hydrothorax and le-
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Figure 2. Clinical features of subjects with CHRNG mutations and Escobar (A–H) and lethal (I and J) variants of MPS. An affected
child from family MPS001 demonstrates an expressionless face and webbing of neck, axillae, and elbows (A); webbing of neck (posterior
view) (B); thumb pterygium and camptodactyly (C); and popliteal pterygia and rocker-bottom feet (D). In family MPS015, an affected
individual has neck pterygium (E) and pterygia and ﬁxed ﬂexion deformities at elbow (F), lower limbs (G), and hand (H). Elbow pterygium
(I [arrow]) and muscle histopathology demonstrate an abnormal myotubular appearance (J) in a case of LMPS (from family MPS008).
thal lung hypoplasia (with normal microscopy) and right
pelvicalyceal dilatation. Muscle bulk appeared normal, and
muscle histopathology was consistent with denervation
(with slow ﬁber predominance, focal ﬁber-type group-
ing, and hypotrophic slow ﬁbers together with some fat
inﬁltration).
There was no apparent correlation between mutation
position and clinical phenotype (see table 1 and ﬁg. 4),
and no evidence of germline CHRNG mutations were de-
tected in ﬁve kindreds with LMPS or four kindreds with
EVMPS. In eight of nine of these kindreds, linkage to
CHRNG was excluded. However, we did detect a possible
splice-site mutation, IVS4-9TrC, in the MPS006 kindred,
in which two affected individuals had an EVMPS pheno-
type. Since CHRNG is expressed only in fetal or denervated
cells, we were unable to study mRNA splicing, but the se-
quence change was absent in 192 ethnically matched con-
trol chromosomes, and allelotyping was consistent with
linkage to CHRNG.
The pathogenesis of most forms of MPS has been un-
clear, although early-onset fetal akinesia, fragile collagen,
and generalized edema have all been implicated. Thus,
multiple pterygia may occur in Bruck syndrome, which is
characterized by bone fragility and arthrogryposis multi-
plex and, in some cases, is caused by mutations in PLOD2,
which catalyzes the hydroxylation of lysyl residues in col-
lagens.7 However, in a review of lethal cases, only a few
were found to have an underlying diagnosis (e.g., speciﬁc
primary myopathy or metabolic or neurodevelopmental
disorder), and there was considerable clinical and patho-
logical heterogeneity.4 Hence, the ﬁnding that a substan-
tial minority of cases of lethal and nonlethal MPS had
germline CHRNG mutations represents a diagnostic ad-
vance and provides an insight into the etiology of MPS
in these patients.
CHRNG encodes the g subunit of the nicotinergic ace-
tylcholine receptor (AChR) of skeletal muscle (CHRN in
humans; Acr in mice). This pentameric transmembrane
protein is composed of four different subunits and exists
in two forms. The adult form is predominant in innervated
adult muscle, and the embryonic form is present in fetal
and denervated muscle. Embryonic AChR comprises two
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Figure 3. Identiﬁcation of a common region of autozygosity in two families with MPS. The smallest region of overlap extended from
D2S1363 to D2S206.
Table 1. Details of MPS-Affected Families with CHRNG Mutations and Sequence Variants
Pedigree Phenotype
Ethnic
Origin
Nucleotide
Alterations
Alterations in
Coding Sequence
Exon/
Intron
Parental
Consanguinity
MPS001 Nonlethal and lethal Arab c.320TrG p.Val107Gly 4 Yes
MPS002 Nonlethal Pakistani c.136CrT p.Arg46X 2 Yes
MPS006 Nonlethal Pakistani IVS4-9TrC Unknown IVS4 Yes
MPS008 Lethal Turkish c.753_754delCT p.Pro251ProfsX46 7 Yes
MPS011 Lethal Whitea c.469dupA p.Val154SerfsX24 5 No
MPS015 Nonlethal Whitea c.401_402delCT p.Pro134Argfsx34 5 No
NOTE.—All patients were homozygous for the sequence alteration indicated.
a From the United Kingdom.
a and single b, g, and d subunits, whereas, in the adult
AChR, the g subunit is replaced by an  subunit.8,9 In ro-
dents, the switch from the g to the  subunit takes place
in the ﬁrst 2 wk of life, but, in humans, the switch occurs
earlier and is apparently complete by 31 wk of gesta-
tion.10,11 The g AChRs and  AChRs have different con-
ductances and opening times, such that the long, open-
time g AChRs generate randommyoﬁber action potentials
from miniature end-plate potentials, whereas the  AChRs
have shorter opening times and higher conductances.8,12
Elsewhere, mutations in AChR subunits have been as-
sociated with congenital myasthenic syndromes (CMS),
genetic disorders of the neuromuscular junction that are
classiﬁed by the site of the transmission defect (presynap-
tic, synaptic, and postsynaptic). Most are postsynaptic and
are associated with AChR deﬁciency due to mutations in
CHRNA1, CHRNB1, CHRND, or CHRNE.13,14 CMS are char-
acterized by muscle weakness, fatigability, and a distinc-
tive electromyographic pattern. The phenotype of CMS
is distinct from that of MPS, although one patient with
CHRND deﬁciency had arthrogryposis, andmild joint con-
tractures may be associated with CMS caused by truncat-
ing mutations in rapsyn.15–17 CMS may also be caused by
mutations in other genes, and these and other proteins
implicated in acetylcholine synthesis might represent fur-
ther candidate genes for MPS in families without CHRNG
mutations.13,18,19
To our knowledge, mutations in CHRNG have not been
described elsewhere in humans, although homozygous g
subunit–deﬁcient mice were born alive and died at age 2
d because of suckling difﬁculty.12 Although these mice did
not show pterygia and were able to move their forelimbs,
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Figure 4. Localization of MPS mutations on the CHRNG gene product that comprises a large extracellular N-terminal ligand-binding
region, three hydrophobic transmembrane domains, a large intracellular region, and a fourth hydrophobic domain. All mutations mapped
to the extracellular or ﬁrst transmembrane domains.
their hindlimbs were immobile. Myasthenia gravis (MG)
is an autoimmune disorder characterized by AChR anti-
bodies. In women with MG, anti-AChR antibodies may
cross the placenta, and ∼20% of infants born to mothers
with MG have transient neonatal myasthenia. The sever-
ity of neonatal MG is highly variable, but, rarely, early
antenatal onset may cause multiple joint contractures and
reduced fetal movements. Such cases are associated with
maternal autoantibodies against the embryonic form of
the AChR.20,21 Since pterygia was not observed in these
cases, it seems that the MPS phenotype results from early-
onset fetal akinesia. Interestingly, antiembryonal AChR an-
tibodies may result not only in arthrogryposis and features
of fetal akinesia but may also be associated with abnor-
malities in the brain and heart.22 We note that the muscle
histopathology associated with CHRNG mutations was
variable and did not provide a consistent indicator for
CHRNG inactivation, although this may be, to some ex-
tent, gestation dependent. However, the muscle histology
is likely to depend on the timing of examination, and the
postnatal changes may reﬂect the developmental effects
of impaired prenatal neuromuscular transmission. Thus,
AChR g subunit–deﬁcient mice do not exhibit the spon-
taneous muscle action potentials that are thought to play
a role in developmental synapse andmuscle maturation.11
However, despite the evidence for a key role of embryonal
AChR function in normal prenatal muscle development,
the g subunit is not required postnatally and, consistent
with this, patients with CHRNG mutations who survived
the perinatal period did not demonstrate marked muscle
weakness. In view of the differences in AChR biology (e.g.,
the timing of the g and  subunit switch) between humans
and rodents, studies of the role of CHRNG mutations in
MPS should provide further insights into the role of the
g AChR in normal human development andmay elucidate
a molecular basis for the phenotypic differences between
lethal and Escobar variants.
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